Published in Clin Microbiol Rev on January 01, 2001
Complete genome sequence of a highly divergent astrovirus isolated from a child with acute diarrhea. Virol J (2008) 2.72
Metagenomic analysis of the viral flora of pine marten and European badger feces. J Virol (2011) 1.79
TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol (2003) 1.58
The structure of a replication initiator unites diverse aspects of nucleic acid metabolism. Proc Natl Acad Sci U S A (2002) 1.41
The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J (2012) 1.17
Torque Teno Virus (TTV) distribution in healthy Russian population. Virol J (2009) 1.14
Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol (2001) 1.06
Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity in the hypervariable region. J Virol (2004) 1.04
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases. J Virol (2003) 1.04
New respiratory viruses and the elderly. Open Respir Med J (2011) 1.02
Small Anellovirus in hepatitis C patients and healthy controls. Emerg Infect Dis (2006) 1.02
Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried. J Clin Microbiol (2005) 1.02
Infection with chicken anaemia virus impairs the generation of pathogen-specific cytotoxic T lymphocytes. Immunology (2003) 0.96
Endogenous retroviral pathogenesis in lupus. Curr Opin Rheumatol (2010) 0.95
Torque teno virus: an improved indicator for viral pathogens in drinking waters. Virol J (2008) 0.94
Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity (2008) 0.93
First time molecular detection and phylogenetic relationships of torque teno sus virus 1 and 2 in domestic pigs in Uganda: further evidence for a global distribution. Virol J (2012) 0.91
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs. J Clin Microbiol (2001) 0.89
Association of torque teno virus (TTV) and torque teno mini virus (TTMV) with liver disease among patients coinfected with human immunodeficiency virus and hepatitis C virus. Eur J Clin Microbiol Infect Dis (2012) 0.88
Viral metagenome analysis to guide human pathogen monitoring in environmental samples. Lett Appl Microbiol (2011) 0.88
Age-specific prevalence, transmission and phylogeny of TT virus in the Czech Republic. BMC Infect Dis (2004) 0.86
Molecular investigation of Torque teno sus virus in geographically distinct porcine breeding herds of Sichuan, China. Virol J (2013) 0.84
Emerging infectious threats to the blood supply: seroepidemiological studies in iran - a review. Transfus Med Hemother (2013) 0.83
Torque teno virus viremia load size in patients with selected congenital defects of innate immunity. Clin Vaccine Immunol (2011) 0.82
Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance. Clin Dev Immunol (2012) 0.82
Phylogenetic analysis of Torque Teno Virus genome from Pakistani isolate and incidence of co-infection among HBV/HCV infected patients. Virol J (2012) 0.82
Validation of SYBR Green based quantification assay for the detection of human Torque Teno virus titers from plasma. Virol J (2013) 0.81
High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. J Clin Pathol (2005) 0.80
Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia. J Virol (2010) 0.80
Molecular detection method for all known genotypes of TT virus (TTV) and TTV-like viruses in thalassemia patients and healthy individuals. J Clin Microbiol (2005) 0.79
Prevalence of transfusion transmitted virus (TTV) genotypes among HCC patients in Qaluobia governorate. Virol J (2007) 0.79
Three new emerging subgroups of Torque teno sus viruses (TTSuVs) and co-infection of TTSuVs with porcine circovirus type 2 in China. Virol J (2013) 0.78
Cloning and expression of N22 region of Torque Teno virus (TTV) genome and use of peptide in developing immunoassay for TTV antibodies. Virol J (2014) 0.77
TTV and HPV co-infection in cervical smears of patients with cervical lesions. BMC Infect Dis (2009) 0.77
T-cell reprogramming through targeted CD4-coreceptor and T-cell receptor expression on maturing thymocytes by latent Circoviridae family member porcine circovirus type 2 cell infections in the thymus. Emerg Microbes Infect (2015) 0.77
Rapid increase in total torquetenovirus (TTV) plasma viremia load reveals an apparently transient superinfection by a TTV of a novel group 2 genotype. J Clin Microbiol (2006) 0.77
Phylogenetic analysis of torque teno virus in hepatitis C virus infected patients in shiraz. Hepat Mon (2012) 0.75
Waterborne Viruses and F-Coliphage in Mixed-Use Watersheds: Microbial Associations, Host Specificity, and Affinities with Environmental/Land Use Factors. Appl Environ Microbiol (2016) 0.75
Torque teno virus among dialysis and renal-transplant patients. Braz J Microbiol (2015) 0.75
Molecular characterization of human Torque Teno virus. Biomed Rep (2015) 0.75
Association Between TT Virus Infection and Cirrhosis in Liver Transplant Patients. Hepat Mon (2015) 0.75
TreeView: an application to display phylogenetic trees on personal computers. Comput Appl Biosci (1996) 56.57
Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature (1979) 15.42
Cloning the differences between two complex genomes. Science (1993) 10.60
DNA replication: the rolling circle model. Cold Spring Harb Symp Quant Biol (1968) 8.37
Possible emergence of new geminiviruses by frequent recombination. Virology (1999) 5.74
A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun (1997) 5.25
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Presence of a newly described human DNA virus (TTV) in patients with liver disease. Lancet (1998) 3.06
Characterization of novel circovirus DNAs associated with wasting syndromes in pigs. J Gen Virol (1998) 2.90
Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78
Sequence of porcine circovirus DNA: affinities with plant circoviruses. J Gen Virol (1997) 2.32
Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci U S A (1999) 2.22
Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis (1999) 2.21
Identification of a novel GC-rich 113-nucleotide region to complete the circular, single-stranded DNA genome of TT virus, the first human circovirus. J Virol (1999) 2.13
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1996) 2.12
Computer-assisted dissection of rolling circle DNA replication. Biosystems (1993) 2.08
Reproduction of lesions of postweaning multisystemic wasting syndrome in gnotobiotic piglets. J Vet Diagn Invest (1999) 1.98
Chicken anemia virus causes apoptosis of thymocytes after in vivo infection and of cell lines after in vitro infection. J Virol (1992) 1.98
TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology (1998) 1.95
Beak and feather disease virus and porcine circovirus genomes: intermediates between the geminiviruses and plant circoviruses. Arch Virol (1998) 1.93
Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs. J Virol (1998) 1.92
Evidence that a plant virus switched hosts to infect a vertebrate and then recombined with a vertebrate-infecting virus. Proc Natl Acad Sci U S A (1999) 1.85
Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol (1998) 1.82
TT virus infection in patients with hepatitis C: frequency, persistence, and sequence heterogeneity. J Infect Dis (1999) 1.76
Detection of a novel strain of porcine circovirus in pigs with postweaning multisystemic wasting syndrome. J Clin Microbiol (1998) 1.73
Mapping and characterization of the origin of DNA replication of porcine circovirus. J Virol (1997) 1.71
Genotype dependence of hepatitis C virus load measurement in commercially available quantitative assays. J Clin Microbiol (1999) 1.68
Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci U S A (1997) 1.63
Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology (1999) 1.59
Presence of antibodies reacting with porcine circovirus in sera of humans, mice, and cattle. Arch Virol (1995) 1.58
Purification and biochemical characterization of chicken anaemia agent. J Gen Virol (1990) 1.58
Psittacine beak and feather disease virus nucleotide sequence analysis and its relationship to porcine circovirus, plant circoviruses, and chicken anaemia virus. Virology (1998) 1.57
Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals. J Gen Virol (1999) 1.57
Transmission of and liver injury by TT virus in patients on maintenance hemodialysis. J Gastroenterol (1999) 1.55
Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol (2000) 1.54
Prevalence of TT virus before and after blood transfusion in patients with chronic liver disease treated surgically for hepatocellular carcinoma. J Gastroenterol Hepatol (1999) 1.50
TT virus infection in hemodialysis patients. Am J Gastroenterol (1999) 1.47
TT virus infection is widespread in the general populations from different geographic regions. J Clin Microbiol (1999) 1.45
Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases. J Hepatol (2000) 1.40
Posttransfusion non-A, non-B hepatitis: physicochemical properties of two distinct agents. J Infect Dis (1983) 1.32
The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): comparison with reported isolates and phylogenetic analysis. Virology (1999) 1.30
Development of a TT virus DNA quantification system using real-time detection PCR. J Clin Microbiol (2000) 1.29
High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatment. J Infect Dis (1999) 1.25
Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines. J Virol (1985) 1.24
Complete circular DNA genome of a TT virus variant (isolate name SANBAN) and 44 partial ORF2 sequences implicating a great degree of diversity beyond genotypes. Virology (1999) 1.24
Immunogenic and protective properties of chicken anaemia virus proteins expressed by baculovirus. Vaccine (1995) 1.20
New genotypes of TT virus (TTV) and a genotyping assay based on restriction fragment length polymorphism. FEBS Lett (1998) 1.20
Global distribution of transfusion-transmitted virus. N Engl J Med (1998) 1.19
Intra-assay performance characteristics of five assays for quantification of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1998) 1.18
TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol (2001) 1.16
Sequence variability among different parvovirus B19 isolates. J Gen Virol (1996) 1.16
Infection with an unenveloped DNA virus (TTV) associated with posttransfusion non-A to G hepatitis in hepatitis patients and healthy blood donors in Thailand. J Med Virol (1998) 1.15
Characterization of a nuclear localization signal of canine parvovirus capsid proteins. Eur J Biochem (1997) 1.14
Two proline-rich nuclear localization signals in the amino- and carboxyl-terminal regions of the Borna disease virus phosphoprotein. J Virol (1998) 1.09
Transfusion-associated TT virus infection and its relationship to liver disease. Hepatology (1999) 1.08
Multiple infection of TT virus (TTV) with different genotypes in Japanese hemophiliacs. Biochem Biophys Res Commun (1999) 1.07
Demonstration of two different types of non-A, non-B hepatitis by reinjection and cross-challenge studies in chimpanzees. Gastroenterology (1981) 1.07
High prevalence of TT virus (TTV) infection in patients on maintenance hemodialysis: frequent mixed infections with different genotypes and lack of evidence of associated liver disease. J Med Virol (1999) 1.06
Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis (1999) 1.05
Sequence heterogeneity of TT virus and closely related viruses. J Virol (2000) 1.04
High prevalence of TT virus infection in healthy children and adults and in patients with liver disease in Taiwan. J Clin Microbiol (1999) 1.04
Determination and phylogenetic analysis of partial sequences from TT virus isolates. J Gen Virol (1999) 1.03
Gene organization of chicken anemia virus. Virology (1995) 1.03
High prevalence of TT virus infection in Brazilian blood donors. J Med Virol (1999) 1.02
TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. J Gen Virol (1999) 1.02
Nicking and joining activity of banana bunchy top virus replication protein in vitro. J Gen Virol (1997) 1.02
Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. J Infect Dis (2000) 1.01
Morphological characterization of chicken anaemia agent (CAA). Arch Virol (1989) 1.01
Detection of TT virus DNA in specimens other than blood. J Clin Virol (1999) 1.01
TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology. J Med Virol (2001) 1.00
High prevalence of TT virus DNA in human saliva and semen. J Clin Microbiol (2000) 0.99
Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells. J Med Virol (1999) 0.99
Transcription analysis of porcine circovirus (PCV). Virus Genes (1998) 0.98
TT viruses (TTV) of non-human primates and their relationship to the human TTV genotypes. J Gen Virol (1999) 0.98
Circular double-stranded forms of TT virus DNA in the liver. J Virol (2000) 0.98
Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae. Pediatr Infect Dis J (2000) 0.98
Excretion into bile of a novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A-G hepatitis. J Infect Dis (1999) 0.98
TT virus infection in nonhuman primates and characterization of the viral genome: identification of simian TT virus isolates. J Virol (2000) 0.96
Transcriptional analysis and genome expression of chicken anaemia virus. J Gen Virol (1994) 0.96
Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection. J Virol (1999) 0.95
Detection of a novel DNA virus (TTV) sequence in peripheral blood mononuclear cells. J Med Virol (1999) 0.94
Replicative forms of TT virus DNA in bone marrow cells. Biochem Biophys Res Commun (2000) 0.94
Analyses of TT virus full-length genomic sequences. J Gen Virol (1999) 0.94
Sequence diversity of TT virus in geographically dispersed human populations. J Gen Virol (1999) 0.94
High prevalence of TT virus (TTV) in naive chimpanzees and in hepatitis C virus-infected humans: frequent mixed infections and identification of new TTV genotypes in chimpanzees. J Gen Virol (2000) 0.93
High prevalance of TT virus infection in Japanese patients with liver diseases and in blood donors. J Hepatol (1999) 0.93
Natural history of the TT virus infection through follow-up of TTV DNA-positive multiple-transfused patients. Blood (2000) 0.92
Species-specific TT viruses and cross-species infection in nonhuman primates. J Virol (2000) 0.92
Mixed viral infection identified using heteroduplex mobility analysis (HMA). Virology (2000) 0.92
Lack of evidence for an association between TTV infection and severe liver disease. J Clin Virol (1998) 0.92
Prevalence and implication of TT virus infection: minimal role in patients with non-A-E hepatitis in Taiwan. J Med Virol (1999) 0.92
Presence of TT virus in French blood donors and intravenous drug users. J Hepatol (1998) 0.92
The role of TT virus infection in acute viral hepatitis. Hepatology (1999) 0.91
Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan. J Virol Methods (1999) 0.91
Extensive homologous recombination among widely divergent TT viruses. J Virol (2000) 0.91
Prevalence of TT virus infection in blood donors with elevated ALT in the absence of known hepatitis markers. Am J Gastroenterol (2000) 0.90
Cloning and sequencing of the genome of chicken anaemia virus (CAV) TK-5803 strain and comparison with other CAV strains. J Vet Med Sci (1996) 0.90
A novel unenveloped DNA virus (TT virus) associated with acute and chronic non-A to G hepatitis. Intervirology (1999) 0.90
Development of an enzyme-linked immunosorbent assay using recombinant chicken anemia virus proteins expressed in a baculovirus vector system. J Vet Med Sci (1998) 0.90
Hepatocellular carcinomas infected with the novel TT DNA virus lack viral integration. Biochem Biophys Res Commun (1998) 0.90
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
The role of antibody concentration and avidity in antiviral protection. Science (1997) 2.45
Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev (1995) 2.06
Prevalence of hepatitis C virus genotypes in Italy. J Clin Microbiol (1994) 1.47
[Studying the course of HIV-1 infection in cell culture]. Orv Hetil (1993) 1.37
High prevalence of TT virus viremia in italian patients, regardless of age, clinical diagnosis, and previous interferon treatment. J Infect Dis (1999) 1.25
Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region. J Clin Microbiol (1997) 1.25
Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol (1993) 1.24
Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications. AIDS Res Hum Retroviruses (1990) 1.24
Partial nucleotide sequencing of six subtype 2c hepatitis C viruses detected in Italy. J Clin Microbiol (1995) 1.20
Induction of protective cytotoxic T cells with viral proteins. Eur J Immunol (1994) 1.19
TT virus (TTV) loads associated with different peripheral blood cell types and evidence for TTV replication in activated mononuclear cells. J Med Virol (2001) 1.16
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity. J Virol (1994) 1.08
Differences in hepatitis C virus quasispecies composition between liver, peripheral blood mononuclear cells and plasma. J Gen Virol (1997) 1.08
Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses. Ann N Y Acad Sci (1995) 1.08
Detection of feline immunodeficiency virus in saliva and plasma by cultivation and polymerase chain reaction. J Clin Microbiol (1993) 1.07
Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol (2001) 1.06
Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J Virol (1996) 1.03
Qualitative and quantitative requirements for CD4+ T cell-mediated antiviral protection. J Immunol (1999) 1.02
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates. J Virol Methods (1997) 1.02
MMTV-like sequences in human breast cancer: a fluorescent PCR/laser microdissection approach. J Pathol (2006) 1.02
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. Acta Virol (1994) 1.02
Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies. J Virol Methods (1992) 1.01
TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology. J Med Virol (2001) 1.00
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol (1999) 0.99
Prenatal BACs-on-Beads™ : a new technology for rapid detection of aneuploidies and microdeletions in prenatal diagnosis. Prenat Diagn (2011) 0.98
Development of feline immunodeficiency virus ORF-A (tat) mutants: in vitro and in vivo characterization. Virology (2002) 0.97
Serological reactivity and viral genotypes in hepatitis C virus infection. J Clin Microbiol (1995) 0.95
HIV-1 NAT minipool during the pre-seroconversion window period: detection of a repeat blood donor. Vox Sang (2006) 0.94
Characterization of T-helper epitopes of the glycoprotein of vesicular stomatitis virus. J Virol (1994) 0.93
Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy. J Interferon Cytokine Res (1999) 0.93
Hepatitis C virus serological and polymerase chain reactions in human immunodeficiency virus-positive and -negative patients. Clin Diagn Virol (1994) 0.93
Reduced sensitivity to strain-specific neutralization of laboratory-adapted feline immunodeficiency virus after one passage in vivo: association with amino acid substitutions in the V4 region of the surface glycoprotein. AIDS Res Hum Retroviruses (1996) 0.92
Comparison of three restriction endonucleases in IS1245-based RFLP typing of Mycobacterium avium. J Med Microbiol (1997) 0.92
Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates. J Virol (1998) 0.91
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders. J Med Virol (2001) 0.91
Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats. J Virol (2000) 0.91
False-positive and false-negative findings on chorionic villus sampling. Prenat Diagn (1987) 0.90
Automated volumetry of pulmonary nodules on multidetector CT: influence of slice thickness, reconstruction algorithm and tube current. Preliminary results. Radiol Med (2008) 0.90
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs. J Clin Microbiol (2001) 0.89
Structural and stereospecific requirements for the nucleoside-triggered germination of Bacillus cereus spores. J Gen Microbiol (1991) 0.89
Detection of salivary antibodies in cats infected with feline immunodeficiency virus. J Clin Microbiol (1992) 0.88
Lentivirus infection in an African lion: a clinical, pathologic and virologic study. J Wildl Dis (1995) 0.88
Analysis of the Mycobacterium bovis hsp60 promoter activity in recombinant Mycobacterium avium. FEMS Microbiol Lett (1998) 0.88
Hepatitis C virus infection: prevalence in psoriasis and psoriatic arthritis. J Rheumatol (1999) 0.87
Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol (1999) 0.87
Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation and PCR analysis. Vet Immunol Immunopathol (1995) 0.87
Phytochemical and antioxidant analysis of eight Hypericum taxa from Central Italy. Fitoterapia (2007) 0.86
TT virus: evidence for transplacental transmission. J Infect Dis (2000) 0.86
Low-dose interferon-alpha treatment for feline immunodeficiency virus infection. Vet Immunol Immunopathol (2005) 0.85
Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy. Clin Exp Immunol (1996) 0.85
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients. Clin Microbiol Infect (2011) 0.85
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens. Clin Diagn Lab Immunol (1998) 0.84
Tumor necrosis factor-alpha and virus expression in the central nervous system of cats infected with feline immunodeficiency virus. J Neurovirol (1999) 0.84
Role of conservative surgery in ovarian cancer: the European experience. Int J Gynecol Cancer (2005) 0.84
Absence of xenotropic murine leukemia virus-related virus in Italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis. Int J Immunopathol Pharmacol (2012) 0.83
Decay of HIV type 1 DNA and development of drug-resistant mutants in patients with primary HIV type 1 infection receiving highly active antiretroviral therapy. AIDS Res Hum Retroviruses (2001) 0.83
TT virus infection of periodontal tissues: a controlled clinical and laboratory pilot study. J Periodontol (2004) 0.83
Torquetenovirus in patients with arthritis. Rheumatology (Oxford) (2007) 0.83
Susceptibility of human and non-human cell lines to HCV infection as determined by the centrifugation-facilitated method. J Virol Methods (1999) 0.82